The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing Sarcoma

Journal of Bone and Joint Surgery

Volumn 80, Issue 7, 1998, Pages 1020-1033

  Wunder, Jay S ^a,b,c   Paulian, Gabe ^a,b   Huvos, Andrew G ^a,b   Heller, Glenn ^a,b   Meyers, Paul A ^a,b   Healey, John H ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISEASE CLASSIFICATION; EWING SARCOMA; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR NECROSIS;

EID: 0031846401     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199807000-00011     Document Type: Article

References (54)

1. Arai, Y.; Kun, L. E.; Brooks, M. T.; Fairclough, D. L.; Fontanesi, J.; Meyer, W. H.; Hayes, F. A.; Thompson, E.; and Rao, B. N.: Ewing's sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy. Internat. J. Radiat. Oncol., Biol., Phys., 21: 1501-1508, 1991.
2. Bacci, G.; Toni, A.; Avella, M.; Manfrini, M.; Sudanese, A.; Ciaroni, D.; Boriani, S.; Emiliani, E.; and Campanacci, M.: Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer, 63: 1477-1486, 1989.
3. Bacci, G.; Picci, P.; Ferrari, S.; Ruggieri, P.; Casadei, R.; Tienghi, A.; Brach del Prever, A.; Gherlinzoni, F.; Mercuri, M.; and Monti, C.: Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer, 72: 3227-3238, 1993.
4. Bacci, G.; Picci, P.; Pignatti, G.; De Cristofaro, R.; Dallari, D.; Avella, M.; Manfrini, M.; Marangolo, M.; Ferruzi, A.; Mercuri, M.; Ruggieri, P.; Biagini, R.; Capanna, R.; Ferrari, S.; Prasad, R.; and Campanacci, M.: Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities. Clin. Orthop., 270: 87-98, 1991.
5. Burdach, S.; Jürgens, H.; Peters, C.; Nürnberger, W.; Mauz-Körholz, C.; Körholz, D.; Paulussen, M.; Pape, H.; Dilloo, D.; Koscielniak, E.; Gadner, H.; and Göbel, U.: Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J. Clin. Oncol., 11: 1482-1488, 1993.
6. Burgert, E. O., Jr.; Nesbit, M. E.; Garnsey, L. A.; Gehan, E. A.; Herrmann, J.; Vietti, T. J.; Cangir, A.; Tefft, M.; Evans, R.; Thomas, P.; Askin, F. B.; Kissane, J. M.; Pritchard, D. J.; Neff, J.; Makley, J. T.; and Gilula, L.: Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup Study IESS-II. J. Clin. Oncol., 8: 1514-1524, 1990.
7. Cangir, A.; Vietti, T. J.; Gehan, E. A.; Burgert, E. O., Jr.; Thomas, P.; Tefft, M.; Nesbit, M. E.; Kissane, J.; and Pritchard, D.: Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer, 66: 887-893, 1990.
8. Delattre, O.; Zucman, J.; Melot, T.; Garau, X. S.; Zucker, J. M.; Lenoir, G. M.; Ambros, P. F.; Sheer, D.; Turc-Carel, C.; Triche, T. J.; Aurias, A.; and Thomas G.: The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. New England J. Med., 331: 294-299, 1994.
9. de Stefani, E.; Carzoglio, J.; Deneo Pellegrini, H.; Olivera, L.; Cendan, M.; and Kasdorf, H.; Ewing's sarcoma: value of tumor necrosis as a predictive factor. Bull. Cancer, 71: 16-21, 1984.
10. DeVita, V. T., Jr.: The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer. Cancer, 51: 1209-1220, 1983.
11. Dunst, J.; Paulussen, M.; and Jurgens, H.: Lung irradiation for Ewing's sarcoma with pulmonary metastases at diagnosis: results of the CESS-studies. Strahlenther. Onkol., 169: 621-623, 1993.
12. Enneking, W. F.; Spanier, S. S.; and Goodman, M. A.: A system for the surgical staging of musculoskeletal sarcoma. Clin. Orthop., 153: 106-120, 1980.
13. Erlemann, R.; Sciuk, J.; Bosse, A.; Ritter, J.; Kusnierz-Glaz, C. R.; Peters, P. E.; and Wuisman, P.: Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology, 175: 791-796, 1990.
14. Evans, R. G.; Nesbit, M. E.; Gehan, E. A.; Garnsey, L. A.; Burgert, O., Jr.; Vietti, T. J.; Cangir, A.; Tefft, M.; Thomas, P.; Askin, F. B.; Kissane, J. M.; Pritchard, D. J.; Neff, J.; Makley, J. T.; and Gilula, L.: Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the Second Intergroup Study. J. Clin. Oncol., 9: 1173-1180, 1991.
15. Evans, R.; Nesbit, M.; Askin, F.; Burgert, O.; Cangir, A.; Foulkes, M.; Gehan, E.; Gilula, L.; Kissane, J.; Makley, J.; Neff, J.; Perez, C.; Pritchard, D.; Tefft, M.; Thomas, P.; and Vietti, T.: Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with nonmetastatic Ewing's sarcoma of the pelvic bones. Internat. J. Radiat. Oncol., Biol., Phys., 11: 129-136, 1985.
16. MIC2. Am. J. Pathol., 139: 317-325, 1991.
17. Fletcher, B. D.; Hanna, S. L.; Fairclough, D. L.; and Gronemeyer, S. A.: Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology, 184: 243-248, 1992.
18. Frouge, C.; Vanel, D.; Coffre, C.; Couanet, D.; Contesso, G.; and Sarrazin, D.: The role of magnetic resonance imaging in the evaluation of Ewing sarcoma. A report of 27 cases. Skel. Radiol., 17: 387-392, 1988.
19. Gobel, V.; Jurgens, H.; Etspuler, G.; Kemperdick, H.; Jungblut, R. M.; Stienen, U.; and Gobel, U.: Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J. Cancer Res. and Clin. Oncol., 113: 187-191, 1987.
20. Golfieri, R.; Baddeley, H.; Pringle, J. S.; Leung, A. W.; Greco, A.; and Souhami, R.: MRI in primary bone tumors: therapeutic implications. European J. Radiol., 12: 201-207, 1991.
21. Hartman, K. R.; Triche, T. J.; Kinsella, T. J.; and Miser, J. S.: Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors. Cancer, 67: 163-171, 1991.
22. Hayes, F. A.; Thompson, E. I.; Meyer, W. H.; Kun, L.; Parham, D.; Rao, B.; Kumar, M.; Hancock, M.; Parvey, L.; Magill, L.; and Hustu, H. O.: Therapy for localized Ewing's sarcoma of bone. J. Clin. Oncol., 7: 208-213, 1989.
23. Holscher, H. C.; Bloem, J. L.; Nooy, M. A.; Taminiau, A. H.; Eulderink, F.; and Hermans, J.: The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. AJR: Am. J. Roentgenol., 154: 763-769, 1990.
24. Huvos, A. G.: Osteogenic sarcoma: pathologic assessment of preoperative (neoadjuvant) chemotherapy. In Bone Tumors: Diagnosis, Treatment, and Prognosis. Ed. 2, pp. 122-128. Philadelphia, W. B. Saunders, 1991.
25. Jentzsch, K.; Binder, H.; Cramer, H.; Glaubiger, D. L.; Kessler, R. M.; Bull, C.; Pomeroy, T. C.; and Gerber, N. L.: Leg function after radiotherapy for Ewing's sarcoma. Cancer, 47: 1267-1278, 1981.
26. Jürgens, H.; Exner, U.; Gadner, H.; Harms, D.; Michaelis, J.; Sauer, R.; Treuner, J.; Voûte, T.; Winkelmann, W.; Winkler, K.; and Göbel, U.: Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer, 61: 23-32, 1988.
27. Kinsella, T. J.; Miser, J. S.; Waller, B.; Venzon, D.; Glatstein, E.; Weaver-McClure, L.; and Horowitz, M. E.: Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy. Internat. J. Radiat. Oncol., Biol., Phys., 20: 389-395, 1991.
28. Kushner, B. H.; Meyers, P. A.; Gerald, W. L.; Healey, J. H.; La Quaglia, M. P.; Boland, P.; Wollner, N.; Casper, E. S.; Aledo, A.; Heller, G.; Schwartz, G. K.; Bonilla, M. A.; Lindsley, K. L.; Merchant, T. E.; Rosenfield, N. S.; Abramson, S. J.; and Cheung, N.-K. V.: Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J. Clin. Oncol., 13: 2796-2804, 1995.
29. Ladanyi, M.: The emerging molecular genetics of sarcoma translocations. Diag. Molec. Pathol., 4: 162-173, 1995.
30. Ladanyi, M.; Heinemann, F. S.; Huvos, A. G.; Rao, P. H.; Chen, Q. G.; and Jhanwar, S. C.: Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases. Human Pathol., 21: 1245-1251, 1990.
31. Ladanyi, M.; Lewis, R.; Garin-Chesa, P.; Rettig, W. J.; Huvos, A. G.; Healey, J. H.; and Jhanwar, S. C.: EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression. Diag. Molec. Pathol., 2: 141-146, 1993.
32. Lang, P.; Vahlensieck, M.; Matthay, K. K.; Johnston, J. O.; Rosenau, W.; Gooding, C. A.; and Genant, H. K.: Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography. Med. and Pediat. Oncol., 26: 329-333, 1996.
33. Lewis, R. J.; Marcove, R. C.; and Rosen, G.: Ewing's sarcoma - functional effects of radiation therapy. J. Bone and Joint Surg., 59-A: 325-331, April 1977.
34. Marcus, R. B., Jr.; Graham-Pole, J. R.; Springfield, D. S.; Fort, J. A.; Gross, S.; Mendenhall, N. P.; Elfenbein, G. J.; Weiner, R. S.; Enneking, W. F.; and Million, R. R.: High-risk Ewing's sarcoma: end-intensification using autologous bone marrow transplantation. Internat. J. Radiat. Oncol., Biol., Phys., 15: 53-59, 1988.
35. Meyers, P. A.; Heller, G.; Healey, J.; Huvos, A.; Lane, J.; Marcove, R.; Applewhite, A.; Vlamis, V.; and Rosen, G.: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J. Clin. Oncol., 10: 5-15, 1992.
36. Miser, J. S.; Kinsella, T. J.; Triche, T. J.; Tsokos, M.; Jarosinski, P.; Forquer, R.; Wesley, R.; and Magrath, I.: Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J. Clin. Oncol., 5: 1191-1198, 1987.
37. Nesbit, M. E., Jr.; Gehan, E. A.; Burgert, E. O., Jr.; Vietti, T. J.; Cangir, A.; Tefft, M.; Evans, R.; Thomas, P.; Askin, F. B.; Kissane, J. M.; Pritchard, D. J.; Herrmann, J.; Neff, J.; Makley, J. T.; and Gilula, L.: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup Study. J. Clin. Oncol., 8: 1664-1674, 1990.
38. Oberlin, O.; Patte, C.; Demeocq, F.; Lacombe, M. J.; Brunat-Mentigny, M.; Demaille, M. C.; Tron, P.; N'Guyen Bui, B.; and Lemerle, J.: The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma. European J. Cancer and Clin. Oncol., 21: 463-467, 1985.
39. Ozaki, T.; Hillman, A.; Hoffman, C.; Rube, C.; Blasius, S.; Dunst, J.; Jurgens, H.; and Winkelmann, W.: Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study. Cancer, 78: 892-900, 1996.
40. Phillips, R. F., and Higinbotham, N. L.: The curability of Ewing's endothelioma of bone in children. J. Pediat., 70: 391-397, 1967.
41. Picci, P.; Sangiorgi, L.; Rougraff, B. T.; Neff, J. R.; Casadei, R.; and Campanacci, M.: Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J. Clin. Oncol., 12: 2699-2705, 1994.
42. Picci, P.; Rougraff, B. T.; Bacci, G.; Neff, J. R.; Sangiorgi, L.; Cazzola, A.; Baldini, N.; Ferrari, S.; Mercuri, M.; Ruggieri, P.; Caldora, P.; Benassi, M. S.; Fabbri, N.; Monti, C.; and Campanacci, M.: Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J. Clin. Oncol., 11: 1763-1769, 1993.
43. Pizzo, P. A.; Horowitz, M. E.; Poplack, D. G.; Hays, D. M.; and Kun, L. E.: Solid tumors of childhood. In Cancer: Principles and Practice of Oncology, edited by V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg. Ed. 4, pp. 1738-1791. Philadelphia, J. B. Lippincott, 1993.
44. Rosen, G.; Caparros, B.; Nirenberg, A.; Marcove, R. C.; Huvos, A. G.; Kosloff, C.; Lane, J.; and Murphy, M. L.: Ewing's sarcoma: ten-year experience with adjuvant chemotherapy. Cancer, 47: 2204-2213, 1981.
45. Rosen, G.; Wollner, N.; Tan, C; Wu, S. J.; Hajdu, S. I.; Cham, W.; D'Angio, G. J.; and Murphy, M. L.: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy. Cancer, 33: 384-393, 1974.
46. Rosen, G.; Caparros, B.; Huvos, A. G.; Kosloff, C.; Nirenberg, A.; Cacavio, A.; Marcove, R. C.; Lane, J. M.; Mehta, B.; and Urban, C.: Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer, 49: 1221-1230, 1982.
47. Sailer, S. L.; Harmon, D. C.; Mankin, H. J.; Truman, J. T.; and Suit, H. D.: Ewing's sarcoma: surgical resection as a prognostic factor. Internat. J. Radiat. Oncol., Biol., Phys., 15: 43-52, 1988.
48. Schmidt, D.; Herrmann, C.; Jurgens, H.; and Harms, D.: Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma. A report from the Kiel Pediatric Tumor Registry. Cancer, 68: 2251-2259, 1991.
49. Springfield, D. S.; Schakel, M. E., Jr.; and Spanier, S. S.: Spontaneous necrosis in osteosarcoma. Clin. Orthop., 263: 233-237, 1991.
50. Strong, L. C.; Herson, J.; Osborne, B. M.; and Sutow, W. W.: Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma. J. Nat. Cancer Inst., 62: 1401-1406, 1979.
51. Thomas, P. R.; Foulkes, M. A.; Gilula, L. A.; Burgert, E. O.; Evans, R. G.; Kissane, J.; Nesbit, M. E.; Pritchard, D. J.; Tefft, M.; and Vietti, T. J.: Primary Ewing's sarcoma of the ribs. A report from the Intergroup Ewing's Sarcoma Study. Cancer, 51: 1021-1027, 1983.
52. Tucker, M. A.; D'Angio, G. J.; Boice, J. D., Jr.; Strong, L. C.; Li, F. P.; Stovallo, M.; Stone, B. J.; Green, D. M.; Lombardi, F.; Newton, W.; Hoover, R. N.; and Fraumeni, J. F., Jr.: Bone sarcomas linked to radiotherapy and chemotherapy in children. New England J. Med., 317: 588-593, 1987.
53. van der Woude, H. J.; Bloem, J. L.; Verstraete, K. L.; Taminiau, A. H.; Nooy, M. A.; and Hogendoorn, P. C.: Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR: Am. J. Roentgenol., 165: 593-598, 1995.
54. Wilkins, R. M.; Pritchard, D. J.; Burgert, E. O., Jr.; and Unni, K. K.: Ewing's sarcoma of bone. Experience with 140 patients. Cancer, 58: 2551-2555, 1986.